Business Context and Reporting Period
Company: Braskem S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Fourth Quarter (4Q) and Full Year ended December 31, 2024.
Business Overview: Braskem is the leading resins producer in the Americas and the world leader in biopolymers. The company operates in Brazil/South America, the United States/Europe, and Mexico.
Key Financial Metrics
Fourth Quarter 2024 (4Q24)
- Recurring EBITDA: US$102 million (R$557 million).
- Operating Cash Generation: R$1.1 billion.
- Recurring Cash Generation: R$265 million.
- Net Loss: US$1.0 billion (R$5.9 billion), primarily driven by R$4.7 billion in negative exchange rate variations.
- Corporate Gross Debt: US$8.6 billion (92% in USD, average term ~9 years).
- Net Debt: US$6.2 billion.
- Cash Position: US$2.4 billion.
- Corporate Leverage: 7.42x.
Full Year 2024
- Recurring EBITDA: US$1.1 billion (46% increase vs. 2023).
- Recurring Cash Generation: Negative R$560 million.
- Net Loss: US$2.2 billion (R$12.1 billion), attributed to R$11.5 billion in negative exchange rate variations.
- Net Loss Attributable to Shareholders: US$2.1 billion (R$11.3 billion).
- Corporate Investments: US$429 million (2% lower than initial estimate).
Material Changes vs. Prior Periods
Quarter-over-Quarter (4Q24 vs. 3Q24)
- Recurring EBITDA: Decreased 76% to US$102 million due to lower international spreads (Main Chemicals -24%, Resins -12%), lower sales volumes (-5%), and higher idleness expenses.
- Revenue: Consolidated revenue declined due to lower resin and chemical sales volumes and reduced international price references.
- Alagoas Provision: Significant increase in provisions for the geological event in Alagoas, including an additional R$1.2 billion for filling pressurized salt cavities.
Year-over-Year (4Q24 vs. 4Q23)
- Recurring EBITDA: Decreased 52% compared to 4Q23, driven by lower spreads and environmental provision updates.
- Full Year EBITDA: Increased 46% compared to 2023.
- Debt Structure: In November 2024, the company repurchased US$369 million of Hybrid Bonds, leaving US$241 million outstanding. In October 2024, a US$850 million bond was issued at 8.00% p.a.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- 2025 Investment Plan: Braskem plans corporate investments of US$404 million (excluding Braskem Idesa and REIQ), representing a 39% reduction from the historical 6-year average. Total planned investment including REIQ is US$484 million.
- Operational Focus: Investments will prioritize scheduled maintenance, asset integrity, and sustainable development goals (30% of corporate investments).
- Braskem Idesa (Mexico): The ethane import terminal (TQPM) is 94% complete with operations expected in Q2 2025. Fitch updated Braskem Idesa's outlook to "Stable" with a "B+" rating.
Risks and Contingencies
- Alagoas Geological Event: A material contingency involving salt mining cavities in Maceió. The company has increased provisions to R$2.6 billion for cavity closure and monitoring. Future costs may vary based on technical studies and legal proceedings.
- Market Conditions: Global petrochemical spreads decreased in 4Q24 due to seasonality, high inventories, and lower demand in key sectors (packaging, construction).
- Currency Exposure: Significant negative impact on net income due to the depreciation of the Brazilian Real against the US Dollar and the use of hedge accounting.
Investor Verification Checklist
- Alagoas Provision Adequacy: Verify the sufficiency of the R$2.6 billion provision for cavity closure and the potential for future cost increases based on the dynamic nature of the geological event.
- Currency Impact: Assess the sensitivity of future earnings to exchange rate fluctuations between the BRL/MXN and USD, given the significant negative exchange variation recorded in 2024.
- Debt Maturity and Liquidity: Confirm the ability to service US$8.6 billion in gross debt with a US$2.4 billion cash position, noting that 68% of debt matures from 2030 onwards.
- Spread Recovery: Monitor the recovery of petrochemical spreads (PE, PP, Main Chemicals) which contracted significantly in 4Q24 due to global demand slowdowns.
- Braskem Idesa Capitalization: Review the impact of the US$1.6 billion shareholder loan capitalization on Braskem Idesa's balance sheet and leverage.